Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28975742 | 0.92 | TSHR (0.39) | CYP2C19ALDH1A1TSHRMEN1GLA | |
| SCHEMBL15360341 | 0.91 | TSHR (0.46) | CYP2C19ALDH1A1TSHRMEN1GLA | |
| SCHEMBL23252205 | 0.91 | TSHR (0.40) | CYP2C19ALDH1A1TSHRMEN1GLA | |
| SCHEMBL449731 | 0.91 | CA12 (0.48) | CYP2C19ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL6510548 | 0.89 | CA12 (0.48) | CYP2C19ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL9465735 | 0.89 | — | — | |
| SCHEMBL16776784 | 0.89 | CA12 (0.50) | CYP2C19ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL5199356 | 0.87 | CYP2C19 (0.48) | CYP2C19ALDH1A1TSHRMEN1GLA | |
| SCHEMBL17644134 | 0.87 | — | — | |
| SCHEMBL15004595 | 0.87 | TSHR (0.54) | CYP2C19ALDH1A1TSHRCYP1A2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116507679-A | Organosilicon emulsion and use thereof | 美国陶氏有机硅公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116457410-A | Sealant composition | 美国陶氏有机硅公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-116348554-A | Two-part condensation curable silicone compositions and their use | 美国陶氏有机硅公司 | 2023-06-27 | — | — | CN | disclosed |
| US-20160090439-A1 | SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-03-31 | — | — | US | disclosed |
| US-20160090439-A1 | SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-03-31 | — | — | US | disclosed |
| US-8840751-B2 | Bonding compositions | Henkel IP & Holding GmbH (DE) | 2014-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090439-A1 | SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF | ILK, CAD, CAPG | CYP2C19 3707/4885ALDH1A1 377/4885TSHR 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.